The global Swine Health Market Study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Product (Diagnostic Tests (Enzyme Linked Immuno-Sorbent Assay (ELISA), Rapid Immuno Migration (RIM), Agar Gel Immuno-Diffusion (AGID), Polymerase Chain Reaction (PCR), Diagnostic Imaging), Therapeutics (Vaccines, Parasiticides, Anti-infectives, Feed additives)), By Disease (Exudative dermatitis, Coccidiosis, Respiratory diseases, Swine dysentery, Porcine parvovirus, Others).
The Swine Health Market includes veterinary products, vaccines, diagnostic tests, and pharmaceuticals used in swine production, pig farming, and livestock management for swine disease prevention, vaccination programs, and health monitoring in swine herds. Swine health solutions encompass disease surveillance, biosecurity measures, vaccination protocols, and animal health management practices to control swine diseases, respiratory infections, gastrointestinal disorders, and reproductive issues in pig populations. Market trends focus on swine health diagnostics, herd health management software, antimicrobial stewardship, and precision livestock farming technologies for sustainable swine production and animal welfare.
The global Swine Health Industry is highly competitive with a large number of companies focusing on niche market segments. Amidst intense competitive conditions, Swine Health Companies are investing in new product launches and strengthening distribution channels. Key companies operating in the Swine Health Industry include- Boehringer Ingelheim GmbH, Ceva Animal Health Inc, Elanco, Huvepharma, IDEXX Laboratories Inc, IDVet, Merck & Co. Inc, Phibro Animal Health, Vetoquinol SA, Virbac, Zoetis Animal Healthcare.
One of the prominent trends in the swine health market is the increasing incidence of swine diseases worldwide. Swine diseases pose significant economic and health challenges to the swine industry, leading to production losses, increased mortality rates, and higher healthcare costs for swine producers. Various factors contribute to the spread of swine diseases, including globalization of trade, intensification of swine production systems, environmental factors, and inadequate biosecurity measures. Diseases such as African Swine Fever (ASF), porcine reproductive and respiratory syndrome (PRRS), swine influenza, and foot-and-mouth disease (FMD) continue to impact swine populations across different regions, emphasizing the importance of disease surveillance, prevention, and control measures in the swine industry. As a result, there is a growing demand for swine health products and services, including vaccines, diagnostics, therapeutics, and biosecurity solutions, to mitigate the risk of disease outbreaks and safeguard swine health and productivity.
The primary driver for the swine health market is the growing emphasis on preventive healthcare and biosecurity practices in swine production systems. Swine producers and veterinarians are adopting proactive strategies to prevent the introduction and spread of infectious diseases in swine herds, recognizing the significant economic and welfare implications of disease outbreaks. Key components of preventive healthcare and biosecurity programs include vaccination protocols, herd health monitoring, quarantine measures, hygiene practices, and facility design to minimize disease transmission and maintain optimal health status in swine populations. Additionally, regulatory requirements and industry standards mandate compliance with biosecurity measures to ensure food safety, animal welfare, and sustainability in swine production. The increasing focus on preventive healthcare and biosecurity drives the demand for swine health products and services that support disease prevention, surveillance, and management, driving market growth in the swine health sector.
An opportunity exists in leveraging advancements in precision livestock farming (PLF) technologies to enhance swine health management and productivity. PLF technologies, such as sensor-based monitoring systems, wearable devices, data analytics platforms, and automated management systems, enable real-time monitoring and management of individual animals, herds, and production environments. These technologies provide valuable insights into animal behavior, health status, feed intake, environmental conditions, and performance indicators, allowing swine producers to make data-driven decisions, optimize production efficiency, and improve animal welfare. By integrating swine health data with PLF solutions, producers can detect early signs of disease, identify risk factors, and implement targeted interventions to prevent disease outbreaks and minimize the use of antibiotics and other therapeutics. Moreover, PLF technologies facilitate remote monitoring and management of swine operations, reducing labor requirements, enhancing operational efficiency, and ensuring compliance with regulatory requirements. Manufacturers and service providers in the swine health market can capitalize on this opportunity by developing innovative PLF solutions tailored to the needs of swine producers, enhancing market competitiveness and value proposition in the swine health sector.
Among the segmented categories, Polymerase Chain Reaction (PCR) Diagnostic Tests emerge as the fast-growing product in the market for swine health. PCR diagnostic tests offer a highly sensitive and specific method for detecting various pathogens and diseases in swine populations, including respiratory diseases, exudative dermatitis, coccidiosis, swine dysentery, porcine parvovirus, and others. With the increasing global demand for pork products and the rising concern over disease outbreaks in swine herds, there is a growing need for accurate and rapid diagnostic tools to monitor and manage swine health effectively. PCR tests enable early detection of pathogens, facilitating timely intervention and disease control measures to prevent economic losses and ensure the welfare of swine populations. As swine producers, veterinarians, and regulatory agencies prioritize disease surveillance and biosecurity measures, the demand for PCR diagnostic tests continues to surge. Moreover, advancements in PCR technology, including the development of multiplex assays and portable testing platforms, further drive the adoption of PCR tests in the swine industry. With their ability to provide rapid and reliable results, PCR diagnostic tests play a crucial role in safeguarding swine health and sustaining the profitability of swine production operations.
By Product
Diagnostic Tests
-Enzyme Linked Immuno-Sorbent Assay (ELISA)
-Rapid Immuno Migration (RIM)
-Agar Gel Immuno-Diffusion (AGID)
-Polymerase Chain Reaction (PCR)
-Diagnostic Imaging
-Others
Therapeutics
-Vaccines
-Parasiticides
-Anti-infectives
-Feed additives
-Others
By Disease
Exudative dermatitis
Coccidiosis
Respiratory diseases
Swine dysentery
Porcine parvovirus
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Boehringer Ingelheim GmbH
Ceva Animal Health Inc
Elanco
Huvepharma
IDEXX Laboratories Inc
IDVet
Merck & Co. Inc
Phibro Animal Health
Vetoquinol SA
Virbac
Zoetis Animal Healthcare
* List not Exhaustive
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Swine Health Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Swine Health Industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Swine Health Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Swine Health Market Size Outlook, $ Million, 2021 to 2030
3.2 Swine Health Market Outlook by Type, $ Million, 2021 to 2030
3.3 Swine Health Market Outlook by Product, $ Million, 2021 to 2030
3.4 Swine Health Market Outlook by Application, $ Million, 2021 to 2030
3.5 Swine Health Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Swine Health Industry
4.2 Key Market Trends in Swine Health Industry
4.3 Potential Opportunities in Swine Health Industry
4.4 Key Challenges in Swine Health Industry
5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Swine Health Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Swine Health Market Outlook by Segments
7.1 Swine Health Market Outlook by Segments, $ Million, 2021- 2030
By Product
Diagnostic Tests
-Enzyme Linked Immuno-Sorbent Assay (ELISA)
-Rapid Immuno Migration (RIM)
-Agar Gel Immuno-Diffusion (AGID)
-Polymerase Chain Reaction (PCR)
-Diagnostic Imaging
-Others
Therapeutics
-Vaccines
-Parasiticides
-Anti-infectives
-Feed additives
-Others
By Disease
Exudative dermatitis
Coccidiosis
Respiratory diseases
Swine dysentery
Porcine parvovirus
Others
8 North America Swine Health Market Analysis and Outlook To 2030
8.1 Introduction to North America Swine Health Markets in 2024
8.2 North America Swine Health Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Swine Health Market size Outlook by Segments, 2021-2030
By Product
Diagnostic Tests
-Enzyme Linked Immuno-Sorbent Assay (ELISA)
-Rapid Immuno Migration (RIM)
-Agar Gel Immuno-Diffusion (AGID)
-Polymerase Chain Reaction (PCR)
-Diagnostic Imaging
-Others
Therapeutics
-Vaccines
-Parasiticides
-Anti-infectives
-Feed additives
-Others
By Disease
Exudative dermatitis
Coccidiosis
Respiratory diseases
Swine dysentery
Porcine parvovirus
Others
9 Europe Swine Health Market Analysis and Outlook To 2030
9.1 Introduction to Europe Swine Health Markets in 2024
9.2 Europe Swine Health Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Swine Health Market Size Outlook by Segments, 2021-2030
By Product
Diagnostic Tests
-Enzyme Linked Immuno-Sorbent Assay (ELISA)
-Rapid Immuno Migration (RIM)
-Agar Gel Immuno-Diffusion (AGID)
-Polymerase Chain Reaction (PCR)
-Diagnostic Imaging
-Others
Therapeutics
-Vaccines
-Parasiticides
-Anti-infectives
-Feed additives
-Others
By Disease
Exudative dermatitis
Coccidiosis
Respiratory diseases
Swine dysentery
Porcine parvovirus
Others
10 Asia Pacific Swine Health Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Swine Health Markets in 2024
10.2 Asia Pacific Swine Health Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Swine Health Market size Outlook by Segments, 2021-2030
By Product
Diagnostic Tests
-Enzyme Linked Immuno-Sorbent Assay (ELISA)
-Rapid Immuno Migration (RIM)
-Agar Gel Immuno-Diffusion (AGID)
-Polymerase Chain Reaction (PCR)
-Diagnostic Imaging
-Others
Therapeutics
-Vaccines
-Parasiticides
-Anti-infectives
-Feed additives
-Others
By Disease
Exudative dermatitis
Coccidiosis
Respiratory diseases
Swine dysentery
Porcine parvovirus
Others
11 South America Swine Health Market Analysis and Outlook To 2030
11.1 Introduction to South America Swine Health Markets in 2024
11.2 South America Swine Health Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Swine Health Market size Outlook by Segments, 2021-2030
By Product
Diagnostic Tests
-Enzyme Linked Immuno-Sorbent Assay (ELISA)
-Rapid Immuno Migration (RIM)
-Agar Gel Immuno-Diffusion (AGID)
-Polymerase Chain Reaction (PCR)
-Diagnostic Imaging
-Others
Therapeutics
-Vaccines
-Parasiticides
-Anti-infectives
-Feed additives
-Others
By Disease
Exudative dermatitis
Coccidiosis
Respiratory diseases
Swine dysentery
Porcine parvovirus
Others
12 Middle East and Africa Swine Health Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Swine Health Markets in 2024
12.2 Middle East and Africa Swine Health Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Swine Health Market size Outlook by Segments, 2021-2030
By Product
Diagnostic Tests
-Enzyme Linked Immuno-Sorbent Assay (ELISA)
-Rapid Immuno Migration (RIM)
-Agar Gel Immuno-Diffusion (AGID)
-Polymerase Chain Reaction (PCR)
-Diagnostic Imaging
-Others
Therapeutics
-Vaccines
-Parasiticides
-Anti-infectives
-Feed additives
-Others
By Disease
Exudative dermatitis
Coccidiosis
Respiratory diseases
Swine dysentery
Porcine parvovirus
Others
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Boehringer Ingelheim GmbH
Ceva Animal Health Inc
Elanco
Huvepharma
IDEXX Laboratories Inc
IDVet
Merck & Co. Inc
Phibro Animal Health
Vetoquinol SA
Virbac
Zoetis Animal Healthcare
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Product
Diagnostic Tests
-Enzyme Linked Immuno-Sorbent Assay (ELISA)
-Rapid Immuno Migration (RIM)
-Agar Gel Immuno-Diffusion (AGID)
-Polymerase Chain Reaction (PCR)
-Diagnostic Imaging
-Others
Therapeutics
-Vaccines
-Parasiticides
-Anti-infectives
-Feed additives
-Others
By Disease
Exudative dermatitis
Coccidiosis
Respiratory diseases
Swine dysentery
Porcine parvovirus
Others
The global Swine Health Market is one of the lucrative growth markets, poised to register a 8.1% growth (CAGR) between 2024 and 2030.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Boehringer Ingelheim GmbH, Ceva Animal Health Inc, Elanco, Huvepharma, IDEXX Laboratories Inc, IDVet, Merck & Co. Inc, Phibro Animal Health, Vetoquinol SA, Virbac, Zoetis Animal Healthcare
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: USD; Volume